Industry sponsored and supported sessions

Nurses Group Symposium
Understanding PNH

Physicians Symposia
Challenging the status quo with novel treatment combinations in relapsed multiple myeloma

Rethinking the role of T cells in ALL

Nurses Group Symposium
Practical considerations for the administration of blinatumomab in adults with relapsed/refractory acute lymphoblastic leukaemia

New perspectives on the management of infectious complications

Basilea Pharmaceutica:
Challenges and recent developments in the management of invasive fungal infections

Cell Medica:
New Avenues in Immunotherapy

CTI & Servier:
Clinical challenges in the management of relapsed/refractory aggressive B-cell NHL: role of salvage options and new perspectives

Francophone Society of Bone Marrow Transplantation and Cellular Therapies (SFGM-TC):
Conditioning Regimens

Multiple Myeloma 2016: The IFM Perspective

Identifying solutions for difficult to treat patients with hematological malignancies

Jazz Pharmaceuticals:
Physicians Symposium
A new dawn in VOD? Revised risk stratification and diagnostic criteria in a serious complication of HSCT

Nurses Group Symposium
VOD: Risk assessment, identification and response

Kiadis Pharma:
Prevention and treatment of relapses after haploidentical HSCT An ideal opportunity for cell-based therapy?

Miltenyi Biotec:
Cell therapy: Emerging strategies and future visions

Pioneering hematopoietic cell engineering

Antifungal prophylaxis: bridging the Gap from Recommendations to Daily Clinical Practice

Neovii Pharmaceuticals:
Long-term Benefits of an anti-T-cell Lymphocyte Immunoglobulin

Novartis Pharmaceuticals Corporation:
Challenges and Opportunities in the Management of Lymphomas

Oxford Immunotec:
The Role of TB & CMV Immunodiagnostics in Haematopoietic Cell Transplant Recipients

Engaging CD22: Target ALL

GVHD: a 2016 update

Stem cell mobilization and autologous transplantation: what’s new?

Takeda Pharmaceuticals International:
Optimising the CD30-positive lymphoma patient’s treatment journey: an interactive, multidisciplinary case-based discussion

The benefits of immunomodulation in Graft versus Host Disease (GvHD) through Extracorporeal Photopheresis (ECP)

Info on Single European Code

EBMT Corporate Sponsors